John Cox
Director, CEO & President · 1 filing · Latest: May 13, 2026
Dyne Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
DYN | John Cox | Director, CEO & President | May 13, 2026 | Sale | $18.36 | 3,311 | $60.8K | 370,834 |